Come up with a name for your new list and we'll add to it:
MimiVax raised a round of funding on August 25, 2015. Investors include
Buffalo Capital Partners.
MimiVax is commercializing intellectual property developed at Roswell Park Cancer Institute (RPCI) through bench to bedside clinical translation. The company is developing immunotherapeutic vaccines a…